Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Clinical Study Evaluating the Safety and Haemostatic Effectiveness of SURGICEL® Powder, in Mild or Moderate Parenchymal or Soft Tissue Bleeding During General, Gynaecological, Urological, and Cardiothoracic Surgery

NCT03762200 is registered in ClinicalTrials.gov with Ethicon, Inc. as lead sponsor.

NCT NCT03762200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03762200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Clinical Study Evaluating the Safety and Haemostatic Effectiveness of SURGICEL® Powder, in Mild or Moderate Parenchymal or Soft Tissue Bleeding During General, Gynaecological, Urological, and Cardiothoracic Surgery
Lead sponsor
Ethicon, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 26, 2018
Completion date
June 3, 2020
Enrollment
103 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhage